These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29203265)

  • 21. Ceruloplasmin, an indicator of copper status.
    Arredondo M; González M; Olivares M; Pizarro F; Araya M
    Biol Trace Elem Res; 2008; 123(1-3):261-9. PubMed ID: 18270661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis.
    Doğan P; Soyuer U; Tanrikulu G
    Br J Dermatol; 1989 Feb; 120(2):239-44. PubMed ID: 2538138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper-related blood indexes in kidney dialysis patients.
    Emenaker NJ; DiSilvestro RA; Nahman NS; Percival S
    Am J Clin Nutr; 1996 Nov; 64(5):757-60. PubMed ID: 8901797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Levels of Cu, Zn, Se and their relation to levels of ceruloplasmin and the activity of antioxidative enzymes].
    Magálová T; Beno I; Brtková A; Mekinová D; Volkovová K; Staruchová M; Tatara M
    Bratisl Lek Listy; 1997 Jan; 98(1):8-11. PubMed ID: 9264806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution].
    Squitti R; Gorgone G; Binetti G; Ghidoni R; Pasqualetti P; Draicchio F; Albini E; Benedetti L; Lucchini R; Rossini PM
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):294-6. PubMed ID: 18409692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review.
    Torsdottir G; Kristinsson J; Snaedal J; Sveinbjörnsdóttir S; Gudmundsson G; Hreidarsson S; Jóhannesson T
    J Neurol Sci; 2010 Dec; 299(1-2):51-4. PubMed ID: 20851426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis.
    Louro MO; Cocho JA; Mera A; Tutor JC
    J Trace Elem Med Biol; 2000 Oct; 14(3):174-8. PubMed ID: 11130855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term penicillamine therapy on erythrocyte CuZn superoxide dismutase activity.
    Marklund SL; Ek B; Steen L
    Scand J Clin Lab Invest; 1984 Feb; 44(1):13-7. PubMed ID: 6701446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
    Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
    Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of non-ceruloplasmin copper to oxidative stress in patients with hepatocellular carcinoma.
    Geetha A; Saranya P; Annie Jeyachristy S; Surendran R; Sundaram A
    Biol Trace Elem Res; 2009 Sep; 130(3):229-40. PubMed ID: 19229483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceruloplasmin in Parkinson's disease and the nonmotor symptoms.
    Zhao X; Shao Z; Zhang Y; Liu F; Liu Z; Liu Z
    Brain Behav; 2018 Jun; 8(6):e00995. PubMed ID: 29733522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of body antioxidant content is related to initiation and progression of Parkinson's disease.
    Fattah A; Amiri F; Mohammadian M; Alipourfard I; Valilo M; Taheraghdam A; Hemmati-Dinarvand M
    Neurosci Lett; 2020 Sep; 736():135297. PubMed ID: 32771603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    Epilepsy Res; 2003 Oct; 56(2-3):147-53. PubMed ID: 14642999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum in chronic arterial occlusion of the lower limbs.
    Iskra M; Majewski W
    J Trace Elem Med Biol; 1999 Jul; 13(1-2):76-81. PubMed ID: 10445222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of copper nutritional status.
    Milne DB
    Clin Chem; 1994 Aug; 40(8):1479-84. PubMed ID: 8044985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of copper status in pregnancy by means of determining the specific oxidase activity of ceruloplasmin.
    Louro MO; Cocho JA; Tutor JC
    Clin Chim Acta; 2001 Oct; 312(1-2):123-7. PubMed ID: 11580917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of superoxide dismutase, diamine oxidase and caeruloplasmin oxidase in the blood of thoroughbreds.
    Smith P; Stubley D; Blackmore DJ
    Res Vet Sci; 1983 Sep; 35(2):160-4. PubMed ID: 6415770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood copper concentrations and cuproenzyme activities in a colony of cats.
    Fascetti AJ; Rogers QR; Morris JG
    Vet Clin Pathol; 2002; 31(4):183-8. PubMed ID: 12447780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.